Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1984 Dec;18(6):823–829. doi: 10.1111/j.1365-2125.1984.tb02551.x

Effect of a new calcium antagonist, tiapamil, in hypertension of the elderly.

P Balansard, F Elkik, J A Levenson, M Ciampi, P Sans
PMCID: PMC1463689  PMID: 6529523

Abstract

The antihypertensive effect of a single oral dose of tiapamil (450 mg) and placebo were compared in a single blind randomized cross-over study in 10 71-86 year old hypertensive patients. Blood pressure (BP) and heart rate (HR) were recorded every 15 min for 12 h by an automatic device. Tiapamil led to a decrease in mean daytime systolic (SBP) and diastolic (DBP) BP from 171 +/- 12/98 +/- 10 mm Hg to 159 +/- 11/90 +/- 9 mm Hg (P less than 0.001) without significant variation in HR. Thereafter patients received tiapamil 450 twice daily; by the seventh day of treatment mean daytime SBP and DBP were 155 +/- 13/85 +/- 14 mm Hg (P less than 0.001 vs placebo). The hourly mean values of SBP recorded for 8/12 h (first tiapamil day) and 10/12 h (seventh tiapamil day) were significantly lower than the corresponding values after placebo. We conclude that tiapamil in the elderly exerts a sustained antihypertensive effect lasting 12 h or more, with only minor variations in HR. This effect predominates on systolic pressure and is significant from the first dose.

Full text

PDF
824

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amery A., Berthaux P., Birkenhäger W., Boel A., Brixko P., Bulpitt C., Clement D., Deruyttere M., de Schaepdryver A., Dollery C. Antihypertensive therapy in patients above age 60. Third interim report of the European Working Party on High blood pressure in Elderly (EWPHE). Acta Cardiol. 1978;33(2):113–134. [PubMed] [Google Scholar]
  2. Borow K. M., Newburger J. W. Noninvasive estimation of central aortic pressure using the oscillometric method for analyzing systemic artery pulsatile blood flow: comparative study of indirect systolic, diastolic, and mean brachial artery pressure with simultaneous direct ascending aortic pressure measurements. Am Heart J. 1982 May;103(5):879–886. doi: 10.1016/0002-8703(82)90403-3. [DOI] [PubMed] [Google Scholar]
  3. Bühler F. R., Hulthén L. Calcium channel blockers: a pathophysiologically based antihypertensive treatment concept for the future? Eur J Clin Invest. 1982 Feb;12(1):1–3. doi: 10.1111/j.1365-2362.1982.tb00930.x. [DOI] [PubMed] [Google Scholar]
  4. Bühler F. R., Kiowski W., van Brummelen P., Amann F. W., Bertel O., Landmann R., Lütold B. E., Bolli P. Plasma catecholamines and cardiac, renal and peripheral vascular adrenoceptor-mediated responses in different age groups of normal and hypertensive subjects. Clin Exp Hypertens. 1980;2(3-4):409–426. doi: 10.3109/10641968009037122. [DOI] [PubMed] [Google Scholar]
  5. Cockcroft D. W., Gault M. H. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41. doi: 10.1159/000180580. [DOI] [PubMed] [Google Scholar]
  6. Debru J. L., Doyon B., Morin B., Mallion J. M., Cau G. Mesure automatique de la pression artérielle par méthode oscillométrique (Dynamap 845). Arch Mal Coeur Vaiss. 1981 Jun;74(Spec No):125–129. [PubMed] [Google Scholar]
  7. Drayer J. I., Weber M. A., DeYoung J. L., Wyle F. A. Circadian blood pressure patterns in ambulatory hypertensive patients: effects of age. Am J Med. 1982 Oct;73(4):493–499. doi: 10.1016/0002-9343(82)90327-8. [DOI] [PubMed] [Google Scholar]
  8. Gould B. A., Mann S., Kieso H., Subramanian V. B., Raftery E. B. The 24-hour ambulatory blood pressure profile with verapamil. Circulation. 1982 Jan;65(1):22–27. doi: 10.1161/01.cir.65.1.22. [DOI] [PubMed] [Google Scholar]
  9. Haeusler G., Eigenmann R., Gerold M., Hefti F., Jovanovic D., Blaber L., Nakamura K., Thorens S. Overview on the pharmacological and toxicological characterization of the calcium antagonist tiapamil. Cardiology. 1982;69 (Suppl):31–57. doi: 10.1159/000173537. [DOI] [PubMed] [Google Scholar]
  10. Henry P. D. Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem. Am J Cardiol. 1980 Dec 1;46(6):1047–1058. doi: 10.1016/0002-9149(80)90366-5. [DOI] [PubMed] [Google Scholar]
  11. Hills M., Armitage P. The two-period cross-over clinical trial. Br J Clin Pharmacol. 1979 Jul;8(1):7–20. doi: 10.1111/j.1365-2125.1979.tb05903.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kannel W. B., Dawber T. R., McGee D. L. Perspectives on systolic hypertension. The Framingham study. Circulation. 1980 Jun;61(6):1179–1182. doi: 10.1161/01.cir.61.6.1179. [DOI] [PubMed] [Google Scholar]
  13. Kannel W. B., Gordan T. Evaluation of cardiovascular risk in the elderly: the Framingham study. Bull N Y Acad Med. 1978 Jun;54(6):573–591. [PMC free article] [PubMed] [Google Scholar]
  14. Kannel W. B., Sorlie P., Gordon T. Labile hypertension: a faulty concept? The Framingham study. Circulation. 1980 Jun;61(6):1183–1187. doi: 10.1161/01.cir.61.6.1183. [DOI] [PubMed] [Google Scholar]
  15. Koch-Weser J. Arterial hypertension in old age. Herz. 1978 Aug;3(4):235–244. [PubMed] [Google Scholar]
  16. Levenson J. A., Simon A. C., Safar M. E., Fiessinger J. N., Housset E. M. Systolic hypertension in arteriosclerosis obliterans of the lower limbs. Clin Exp Hypertens A. 1982;4(7):1059–1072. [PubMed] [Google Scholar]
  17. Levenson J., Simon A., Maarek B., Totomoukouo J., Gitelman R., Bouthier J., Safar M. Comparative effects of beta-adrenergic blockade in systolic hypertension according to age. Eur Heart J. 1983 Nov;4 (Suppl G):51–54. doi: 10.1093/eurheartj/4.suppl_g.51. [DOI] [PubMed] [Google Scholar]
  18. Lévy S., Burtey J. P., Labrunie P., Faugère G., Valeix B., Cano J. P., Gérard R. Electrophysiology of tiapamil in humans. Cardiology. 1982;69 (Suppl):117–123. [PubMed] [Google Scholar]
  19. Silas J. H., Barker A. T., Ramsay L. E. Clinical evaluation of Dinamap 845 automated blood pressure recorder. Br Heart J. 1980 Feb;43(2):202–205. doi: 10.1136/hrt.43.2.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Simon A. C., Levenson J. A., Safar M. E. Systolic hypertension: differences of mechanism according to age and possible application to treatment. Eur Heart J. 1982 Oct;3 (Suppl 100):65–69. doi: 10.1093/eurheartj/3.suppl_c.65. [DOI] [PubMed] [Google Scholar]
  21. Simon A. C., Safar M. A., Levenson J. A., Kheder A. M., Levy B. I. Systolic hypertension: hemodynamic mechanism and choice of antihypertensive treatment. Am J Cardiol. 1979 Sep;44(3):505–511. doi: 10.1016/0002-9149(79)90404-1. [DOI] [PubMed] [Google Scholar]
  22. Thorens S., Haeusler G. Effects of some vasodilators on calcium translocation in intact and fractionated vascular smooth muscle. Eur J Pharmacol. 1979 Feb 15;54(1-2):79–91. doi: 10.1016/0014-2999(79)90410-2. [DOI] [PubMed] [Google Scholar]
  23. Wendt G. Pharmacokinetics and metabolism of tiapamil. Cardiology. 1982;69 (Suppl):68–78. doi: 10.1159/000173539. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES